This highlights the potential treatment role of targeting the NLRP3 pathway in managing cardiac complications associated with dysbiosis and LPS-induced inflammation
Curr Treat Options Neurol (2014) 16(6):292.10.1007/s11940-014-0292-7 47 OgleRFChristodoulouJFaganEBlokRBKirbyDMSellerKLet alMitochondrial myopathy with tRNA(Leu(UUR)) mutation and complex I deficiency responsive to riboflavin
519 While early models have shown promising results, the application of GLP-1RAs in cancer treatment has not yet been established and requires further clinical trials
doi: 10.1128/JB.187.11.3839-3847.2005 [DOI] [PMC free article] [PubMed] [Google Scholar] 49.Jwk K, Gan Y-H
PubMed, doi:10.1016/j.ejogrb.2014.02.036.Ahern, Thomas P., et al
Despite being a relatively investigated oxidative cell death mechanism, much about its role in various conditions remains to be elucidated